TelyRx Holdings Inc.

TelyRx Holdings Inc. recorded two insider trading transactions during June 2026. Director Robert Sean Foley executed consecutive open market purchases totaling 45,770 CAD. These acquisitions involved 19,900 shares acquired across two days. No divestments occurred within this period, reflecting a singular focus on increasing equity positions by this board member.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Foley, Robert Sean Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
182.31
Quantity 76,436 -30.0%
Value CA$3,440,132
Foley, Robert Sean Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
491.83
Quantity 88,032 -47.2%
Value CA$2,514,537
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase

Director of Issuer

Non-Executive Director
76,436 -30.0%
182.31
CA$3,440,132
76,436 -30.0% 182.31 CA$3,440,132
2026-06-15 2026-06-11 B Purchase

Director of Issuer

Non-Executive Director
88,032 -47.2%
491.83
CA$2,514,537
88,032 -47.2% 491.83 CA$2,514,537
Explore more

More insider trading research around TelyRx Holdings Inc.